ritonavir mylan
mylan s.a.s - ритонавир - ХИВ инфекции - Антивирусни средства за системно приложение - Ритонавир е показан в комбинация с други антиретровирусни средства за лечение на инфектирани с hiv 1 пациенти (възрастни и деца на 2-годишна възраст и по-големи).
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - клопидогрел хидрохлорид - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - Антитромботични агенти - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
levofloxacin mylan 250 mg/50 ml solution for infusion
mylan s.a.s. - Левофлоксацин - 250 mg/50 ml solution for infusion
levofloxacin mylan 500 mg/100 ml solution for infusion
mylan s.a.s. - Левофлоксацин - 500 mg/100 ml solution for infusion
ampicillin & sulbactam mylan l g/0,5 g powder for solution for injection or infusion
mylan s.a.s. - Ампицилин, Сульбактам - l g/0,5 g powder for solution for injection or infusion
ampicillin & sulbactam mylan 2 g/l g powder for solution for injection or infusion
mylan s.a.s. - Ампицилин, Сульбактам - 2 g/l g powder for solution for injection or infusion
oxaliplatin mylan 5 mg/ml concentrate for solution for infusion
mylan s.a.s. - 5 mg/ml concentrate for solution for infusion
epirubicin mylan 2 mg/ml solution for injection or infusion
mylan s.a.s. - 2 mg/ml solution for injection or infusion
docetaxel mylan 40 mg/ml concentrate and solvent for solution for infusion
mylan s.a.s. - docetaxel - 40 mg/ml concentrate and solvent for solution for infusion
vinorelbine mylan 10 mg/ml concentrate for solution for infusion
mylan s.a.s. - 10 mg/ml concentrate for solution for infusion